Best Peptides for Achilles Tendinopathy

Achilles tendinopathy involves degenerative changes and inflammation in the Achilles tendon, typically resulting from chronic overuse or repetitive strain. Research peptides are being investigated for their potential to promote collagen synthesis, enhance tendon healing, and modulate inflammatory responses in damaged tendon tissue. Peptides such as BPC-157 and TB-500 have gained attention in research contexts for their proposed roles in tissue repair and growth factor signaling, though human clinical evidence remains limited.

Research protocols for tendon-related peptides typically employ subcutaneous or localized injection approaches, with dosing schedules ranging from daily to several times weekly depending on the specific peptide and study design. Treatment duration in research settings generally spans 4-12 weeks, though optimal protocols for Achilles tendinopathy specifically remain under investigation.